'''Ifenprodil''' is an inhibitor of the [[NMDA receptor]],<ref name="pmid2555674">{{cite journal |vauthors=Reynolds IJ, Miller RJ |title=Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines |journal=Mol. Pharmacol. |volume=36 |issue=5 |pages=758–65 |year=1989 |pmid=2555674 |doi=}}</ref> specifically of GluN1 (glycine-binding NMDA receptor subunit 1) and GluN2B (glutamate-binding NMDA receptor subunit 2) subunits.<ref>{{cite journal |vauthors=Korinek M, Kapras V, Vyklicky V, Adamusova E, Borovska J, Vales K, Stuchlik A, Horak M, Chodounska H, ((Vyklicky L Jr)) |title=Neurosteroid modulation of N-methyl-d-aspartate receptors: Molecular mechanism and behavioral effects |journal=Steroids |volume=76 |issue=13 |pages=1409–18 |date=Dec 2011 |pmid= 21925193 |doi=10.1016/j.steroids.2011.09.002 }}</ref> Additionally, ifenprodil inhibits GIRK channels, and interacts with alpha1 adrenergic, serotonin, and sigma receptors.<ref>{{cite journal|last1=Kobayashi|first1=Toru|last2=Washiyama|first2=Kazuo|last3=Ikeda|first3=Kazutaka|title=Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Ifenprodil|journal=Neuropsychopharmacology|date=3 August 2005|volume=31|issue=3|pages=516–524|doi=10.1038/sj.npp.1300844|pmid=16123769}}</ref>
